Amplification or overexpression of CCND1 has been shown to play a pivotal role in the development of several human cancers, including parathyroid adenoma, breast cancer, colon cancer, lymphoma, melanoma, and prostate cancer [52]. Here, CCND1 is linked to melanoma.